Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Plasma Hydrogenated Cationic Detonation Nanodiamonds Efficiently Deliver To Human Cells In Culture Functional SiRNA Targeting The Ewing Sarcoma Junction Oncogene.

J. Bertrand, C. Pioche-Durieu, J. Ayala, T. Petit, Hugues A. Girard, Claude P. Malvy, E. le Cam, F. Treussart, Jean-Charles Arnault
Published 2015 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The expression of a defective gene can lead to major cell dysfunctions among which cell proliferation and tumor formation. One promising therapeutic strategy consists in silencing the defective gene using small interfering RNA (siRNA). In previous publications we showed that diamond nanocrystals (ND) of primary size 35 nm, rendered cationic by polyethyleneimine-coating, can efficiently deliver siRNA into cell, which further block the expression of EWS/FLI-1 oncogene in a Ewing sarcoma disease model. However, a therapeutic application of such nanodiamonds requires their elimination by the organism, particularly in urine, which is impossible for 35 nm particles. Here, we report that hydrogenated cationic nanodiamonds of primary size 7 nm (ND-H) have also a high affinity for siRNA and are capable of delivering them in cells. With siRNA/ND-H complexes, we measured a high inhibition efficacy of EWS/FLI-1 gene expression in Ewing sarcoma cell line. Electron microscopy investigations showed ND-H in endocytosis compartments, and especially in macropinosomes from which they can escape before siRNA degradation occurred. In addition, the association of EWS/FLI-1 silencing by the siRNA/ND-H complex with a vincristine treatment yielded a potentiation of the toxic effect of this chemotherapeutic drug. Therefore ND-H appears as a promising delivery agent in anti-tumoral gene therapy.
This paper references
10.1016/J.DIAMOND.2010.03.019
Hydrogenation of nanodiamonds using MPCVD: A new route toward organic functionalization
H. Girard (2010)
10.1002/HON.766
Regulation of apoptosis and proliferation in Ewing's sarcoma—opportunities for targeted therapy
U. Kontny (2006)
10.3109/17435390.2013.855828
Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell lines
V. Paget (2014)
EWS / FLI1 silencing and gene pro fi ling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin - like growth factor binding protein 3
A Prieur (2004)
10.1128/MCB.24.16.7275-7283.2004
EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3
Alexandre Prieur (2004)
10.1039/c1cp20424f
Surface properties of hydrogenated nanodiamonds: a chemical investigation.
H. Girard (2011)
10.1021/nn900865g
Polymer-functionalized nanodiamond platforms as vehicles for gene delivery.
Xue-Qing Zhang (2009)
10.1038/nnano.2008.99
Mass production and dynamic imaging of fluorescent nanodiamonds.
Yi-Ren Chang (2008)
10.1007/978-94-017-8896-0
Intracellular Delivery II
A. Prokop (2014)
10.1002/ADFM.201102670
Functionality is Key: Recent Progress in the Surface Modification of Nanodiamond
A. Krueger (2012)
10.1039/c1cp20109c
Surface chemical modifications and surface reactivity of nanodiamonds hydrogenated by CVD plasma.
Jean-Charles Arnault (2011)
10.1039/c1nr10278h
Triggered release of therapeutic antibodies from nanodiamond complexes.
Adrienne Smith (2011)
10.1021/JZ1013278
Nanodiamond Vectors Functionalized with Polyethylenimine for siRNA Delivery
M. Chen (2010)
10.1371/journal.pone.0052207
Influence of the Internalization Pathway on the Efficacy of siRNA Delivery by Cationic Fluorescent Nanodiamonds in the Ewing Sarcoma Cell Model
A. Alhaddad (2012)
10.2217/nnm.13.183
Biomedical applications of nanodiamonds in imaging and therapy.
E. Perevedentseva (2013)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1158/1078-0432.CCR-05-1778
Insulin-Like Growth Factor I Receptor Pathway Inhibition by ADW742, Alone or in Combination with Imatinib, Doxorubicin, or Vincristine, Is a Novel Therapeutic Approach in Ewing Tumor
A. S. Martins (2006)
10.1038/nnano.2011.209
The properties and applications of nanodiamonds.
V. Mochalin (2011)
The longterm stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent. Biomaterials 2012;33:7794e802
V Vaijayanthimala (2012)
10.1039/c3nr02492j
Surface transfer doping can mediate both colloidal stability and self-assembly of nanodiamonds.
T. Petit (2013)
10.1002/smll.201101193
Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.
A. Alhaddad (2011)
10.1002/pbc.24621
Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
A. Raciborska (2013)
10.1002/smll.200800655
Detection of single photoluminescent diamond nanoparticles in cells and study of the internalization pathway.
O. Faklaris (2008)
Intracellular delivery II, vol
J Slegerova (2014)
10.1016/j.biomaterials.2012.06.084
The long-term stability and biocompatibility of fluorescent nanodiamond as an in vivo contrast agent.
V. Vaijayanthimala (2012)



This paper is referenced by
10.1016/J.DIAMOND.2018.03.015
X-ray Photoemission Spectroscopy applied to nanodiamonds: From surface chemistry to in situ reactivity
J. Arnault (2018)
10.1021/acs.jmedchem.8b01387
Design, Synthesis, and Characterization of Globular Orphan Nuclear Receptor Regulator with Biological Activity in Soft Tissue Sarcoma.
M. Ye (2018)
10.1088/1361-6528/aa6ae4
Biomedical applications of nanodiamond (Review).
K. Turcheniuk (2017)
10.3390/nano10030553
Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution
S. Claveau (2020)
10.1007/S10895-016-1928-7
Redox and Organic Post-Annealing Chemical Processes Impacting the Fluorescence of N V - Centers into Nanodiamonds : A Competitive Process Between Exfoliation and Functionalisation.
P. Babilotte (2016)
10.1039/c7bm00008a
Recent advances in carbon based nanosystems for cancer theranostics.
S. Augustine (2017)
10.3390/mi9050247
Fluorescent Nanodiamond Applications for Cellular Process Sensing and Cell Tracking
S. Claveau (2018)
10.1016/J.DIAMOND.2017.09.012
Photoluminescence of HPHT diamonds synthesized in the Mg-Ge-C system
A. Komarovskikh (2017)
10.1002/PSSA.201600030
pH‐responsive phenylboronic acid‐modified diamond particles: Switch in carbohydrate capture ability triggers modulation of physicochemical and lectin‐recognition properties
Manakamana Khanal (2016)
10.1007/978-3-319-28782-9_1
Nanodiamonds: From Synthesis and Purification to Deposition Techniques, Hybrids Fabrication and Applications
J. Arnault (2016)
10.1021/acsami.7b09624
Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces.
Dae Gon Lim (2017)
10.1002/9781119429418.ch6
Advanced Materials Designed with Nanodiamonds: Synthesis and Applications
Jean-Charles Arnault (2020)
10.1117/12.2256800
Commercial quantities of ultrasmall fluorescent nanodiamonds containing color centers
O. Shenderova (2017)
10.1116/1.4927679
Science and engineering of nanodiamond particle surfaces for biological applications (Review).
O. Shenderova (2015)
10.1016/j.ijpharm.2016.06.004
Combinatorial nanodiamond in pharmaceutical and biomedical applications.
Dae Gon Lim (2016)
10.1016/J.COSSMS.2016.06.007
Hydrogenated nanodiamonds: Synthesis and surface properties
J. Arnault (2017)
Fluorescent nanodiamonds as siRNA vectors : in vitro efficacy evaluation and high-content/high-resolution quantifications of their distribution in vivo. (Nanodiamants fluorescents pour la vectorisation de siRNA : évaluation in vitro et quantifications haut-débit/haute-résolution in vivo)
S. Claveau (2018)
10.1016/j.mce.2016.11.018
Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
Y. Yang (2017)
10.1007/s10853-016-0475-6
Facile synthesis of cationic polymer functionalized nanodiamond with high dispersity and antibacterial activity
Weiwei Cao (2016)
10.1016/J.COSSMS.2016.05.008
Coating nanodiamonds with biocompatible shells for applications in biology and medicine
Jitka Neburková (2017)
10.1039/c9nr01555h
Using hydrogen isotope incorporation as a tool to unravel the surfaces of hydrogen-treated nanodiamonds.
Émilie Nehlig (2019)
10.1007/s13206-017-2209-5
Electrostatically Self-assembled Quinazoline-based Anticancer Drugs on Negatively-charged Nanodiamonds for Overcoming the Chemoresistances in Lung Cancer Cells
Anh Thu Ngoc Lam (2018)
10.1021/acsnano.8b03684
Nanomedicines for Pediatric Cancers.
C. Rodríguez-Nogales (2018)
10.1039/c6cs00109b
Diamond nanostructures for drug delivery, bioimaging, and biosensing.
Xian-feng Chen (2017)
10.1007/978-3-319-09834-0_4
Surface Modifications of Nanodiamonds and Current Issues for Their Biomedical Applications
J. Arnault (2015)
10.1016/j.ijpharm.2018.12.090
Nanodiamonds: Minuscule gems that ferry antineoplastic drugs to resistant tumors
M. S. Ali (2019)
10.1080/09506608.2019.1622202
Surface engineering and applications of nanodiamonds in cancer treatment and imaging
H. Lai (2020)
10.1002/9781119373476.CH2
Using Polymers to Enhance the Carbon Nanomaterial Biointerface
G. Pramanik (2018)
10.5772/63549
The Application of Nanodiamond in Biotechnology and Tissue Engineering
L. Bačáková (2016)
10.20944/preprints202002.0115.v1
Delivery of siRNA to Ewing Sarcoma Tumor Xenografted on Mice, Using Hydrogenated Detonation Nanodiamonds: Treatment Efficacy and Tissue Distribution
S. Claveau (2020)
10.1016/j.carbon.2020.12.043
Electron emission from H-terminated diamond enhanced by polypyrrole grafting
Egor Ukraintsev (2020)
10.1039/C5TB01602A
RGDS covalently surfaced nanodiamond as a tumor targeting carrier of VEGF-siRNA: synthesis, characterization and bioassay.
Chunying Cui (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar